Concurrent antiandrogen therapy in the salvage radiotherapy setting for recurrent prostate cancer: a literature review
Saved in:
Published in | Prostate international |
---|---|
Main Authors | , , , |
Format | Journal Article |
Language | English |
Published |
01.11.2024
|
Online Access | Get full text |
Cover
Loading…
Author | Zhang, Tina Peacock, Michael Mannar, Dhiraj Urban, Ryan |
---|---|
Author_xml | – sequence: 1 givenname: Dhiraj surname: Mannar fullname: Mannar, Dhiraj – sequence: 2 givenname: Ryan orcidid: 0000-0002-2929-5565 surname: Urban fullname: Urban, Ryan – sequence: 3 givenname: Tina orcidid: 0000-0002-7229-6686 surname: Zhang fullname: Zhang, Tina – sequence: 4 givenname: Michael orcidid: 0009-0005-7212-4891 surname: Peacock fullname: Peacock, Michael |
BookMark | eNo1kM9OwzAMh3MYEmPsCbjkBVriZO1SbmjinzSJy-5RmrklU0krJyva29MN5outn-VP1nfHZqEPyNgDiBwElI-HfKDgu1wKucoBciFgxuZS6nWmtZa3bBnjQUxVraCqijkbN31wRyIMiduQvA176lsMPH0h2eHE_WXk0XajbZGT3fv-uouYkg8tb3rihFfMQH1MNiF3NjikJ25559N0kY40AXD0-HPPbhrbRVz-9wXbvb7sNu_Z9vPtY_O8zVylIcMVKCHXat3UAGWNTVVWiFhoWdZWCw12r5xALZRWrgZXFq6cYi0a7aSThVow9Yd100-RsDED-W9LJwPCnIWZg7kIM2dhBsBMwtQvcyNnPQ |
Cites_doi | 10.1016/j.euo.2018.04.014 10.1016/j.annonc.2023.11.017 10.1038/s41391-024-00811-5 10.1200/JCO.20.00818 10.1200/JCO.2017.73.9987 10.1158/0008-5472.CAN-15-0892 10.1016/j.eururo.2013.08.022 10.1001/jamaoncol.2023.0998 10.1016/j.ijrobp.2016.08.043 10.1016/S1470-2045(21)00705-1 10.1016/j.prnil.2023.04.001 10.1002/jcb.20228 10.1016/j.prnil.2024.03.001 10.1016/S1470-2045(20)30456-3 10.1016/S1470-2045(16)00111-X 10.1016/j.juro.2006.10.097 10.1016/j.radonc.2017.10.022 10.1016/j.eururo.2023.03.001 10.1016/S0140-6736(18)32487-5 10.1001/jamaoncol.2019.0096 10.1093/jnci/djj190 10.1001/jamaoncol.2020.0109 10.1056/NEJMoa1607529 10.1016/S0140-6736(20)31952-8 10.1074/jbc.M111.261933 10.1016/S1470-2045(19)30486-3 10.1158/2159-8290.CD-13-0108 10.1002/pros.23445 10.1200/jco.2013.31.6_suppl.167 10.1200/JCO.20.03714 10.1158/2159-8290.CD-13-0172 10.1016/S0140-6736(20)31553-1 10.1001/jamaoncol.2020.0147 10.1200/JCO.2016.67.9647 10.1016/j.ijrobp.2022.12.035 10.1016/S0140-6736(21)01790-6 10.1016/S1470-2045(20)30730-0 10.1038/s41419-022-05084-1 10.2147/RRU.S303215 10.1038/s41598-024-51389-w 10.1016/j.eururo.2021.05.033 10.1371/journal.pone.0066855 10.1016/j.eururo.2020.11.021 10.1016/j.radonc.2023.109544 10.1001/jamaoncol.2017.0751 10.1016/j.eururo.2014.07.010 10.1016/j.eururo.2017.06.027 10.1200/JCO.2006.08.9607 10.1200/JCO.22.00970 10.1001/jama.281.17.1591 10.1016/j.ijrobp.2019.09.047 10.1016/j.juro.2016.08.106 10.1016/S0140-6736(20)30314-7 10.1038/s41391-022-00598-3 10.1200/JCO.21.02741 10.1001/jamanetworkopen.2021.40803 10.1038/s41585-021-00470-4 10.1016/j.juro.2016.07.073 10.1001/jamanetworkopen.2023.32900 10.1200/JCO.2023.41.6_suppl.303 |
ContentType | Journal Article |
DBID | AAYXX CITATION |
DOI | 10.1016/j.prnil.2024.11.001 |
DatabaseName | CrossRef |
DatabaseTitle | CrossRef |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
ExternalDocumentID | 10_1016_j_prnil_2024_11_001 |
GroupedDBID | .1- .FO 0R~ 0SF 4.4 457 53G 5VS 6I. AACTN AAEDW AAFTH AALRI AAXUO AAYXX ABMAC ACGFS ADBBV ADEZE ADRAZ ADVLN AEXQZ AFCTW AFRHN AFTJW AGHFR AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS BCNDV CITATION DIK EBS EJD FDB GROUPED_DOAJ HYE IPNFZ KQ8 M41 M48 NCXOZ O9- OK1 PGMZT RIG ROL RPM SSZ Z5R |
ID | FETCH-LOGICAL-c981-e41302737fb116bef969eee5826ba8081ad3c0e80383cb1c65c680880f8c2c253 |
IEDL.DBID | M48 |
ISSN | 2287-8882 |
IngestDate | Wed Nov 27 13:02:40 EST 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c981-e41302737fb116bef969eee5826ba8081ad3c0e80383cb1c65c680880f8c2c253 |
ORCID | 0000-0002-2929-5565 0000-0002-7229-6686 0009-0005-7212-4891 |
OpenAccessLink | https://dx.doi.org/10.1016/j.prnil.2024.11.001 |
ParticipantIDs | crossref_primary_10_1016_j_prnil_2024_11_001 |
PublicationCentury | 2000 |
PublicationDate | 2024-11-00 |
PublicationDateYYYYMMDD | 2024-11-01 |
PublicationDate_xml | – month: 11 year: 2024 text: 2024-11-00 |
PublicationDecade | 2020 |
PublicationTitle | Prostate international |
PublicationYear | 2024 |
References | Nguyen (10.1016/j.prnil.2024.11.001_bib26) 2015; 67 Wang (10.1016/j.prnil.2024.11.001_bib33) 2023; 26 Jackson (10.1016/j.prnil.2024.11.001_bib52) 2022; 40 Nguyen (10.1016/j.prnil.2024.11.001_bib58) 2023; 116 Pisansky (10.1016/j.prnil.2024.11.001_bib9) 2016; 96 Ziółkowska (10.1016/j.prnil.2024.11.001_bib25) 2012; 16 Pianou (10.1016/j.prnil.2024.11.001_bib62) 2019; 22 Schmidt-Hegemann (10.1016/j.prnil.2024.11.001_bib31) 2023; 183 Fendler (10.1016/j.prnil.2024.11.001_bib64) 2019; 5 Carrie (10.1016/j.prnil.2024.11.001_bib42) 2016; 17 Phillips (10.1016/j.prnil.2024.11.001_bib67) 2020; 6 Byrne (10.1016/j.prnil.2024.11.001_bib16) 2018; 126 Qi (10.1016/j.prnil.2024.11.001_bib10) 2020; 106 Palma (10.1016/j.prnil.2024.11.001_bib65) 2020; 38 Jairath (10.1016/j.prnil.2024.11.001_bib59) 2021; 79 Spratt (10.1016/j.prnil.2024.11.001_bib37) 2015; 75 Armstrong (10.1016/j.prnil.2024.11.001_bib68) 2024 Spratt (10.1016/j.prnil.2024.11.001_bib55) 2018; 73 Dess (10.1016/j.prnil.2024.11.001_bib41) 2020; 6 Chen (10.1016/j.prnil.2024.11.001_bib23) 2022; 13 Jia (10.1016/j.prnil.2024.11.001_bib53) 2003; 1 Erho (10.1016/j.prnil.2024.11.001_bib57) 2013; 8 Parker (10.1016/j.prnil.2024.11.001_bib45) 2024 Vale (10.1016/j.prnil.2024.11.001_bib13) 2020; 396 Tendulkar (10.1016/j.prnil.2024.11.001_bib15) 2016; 34 Tilki (10.1016/j.prnil.2024.11.001_bib8) 2021; 39 Mir (10.1016/j.prnil.2024.11.001_bib2) 2014; 66 Ghashghaei (10.1016/j.prnil.2024.11.001_bib36) 2018; 78 Cookson (10.1016/j.prnil.2024.11.001_bib1) 2007; 177 Parker (10.1016/j.prnil.2024.11.001_bib7) 2020; 396 Lokeshwar (10.1016/j.prnil.2024.11.001_bib30) 2021; 18 Stephenson (10.1016/j.prnil.2024.11.001_bib3) 2006; 98 Meerpohl (10.1016/j.prnil.2024.11.001_bib56) 2014 Kim (10.1016/j.prnil.2024.11.001_bib54) 2004; 93 Parker (10.1016/j.prnil.2024.11.001_bib46) 2024 Fecteau (10.1016/j.prnil.2024.11.001_bib39) 2024 Sobol (10.1016/j.prnil.2024.11.001_bib6) 2017; 197 Carrie (10.1016/j.prnil.2024.11.001_bib43) 2019; 20 Ghadjar (10.1016/j.prnil.2024.11.001_bib11) 2021; 80 Huggins (10.1016/j.prnil.2024.11.001_bib22) 1941; 1 Palma (10.1016/j.prnil.2024.11.001_bib66) 2019; 393 Kneebone (10.1016/j.prnil.2024.11.001_bib12) 2020; 21 Hofman (10.1016/j.prnil.2024.11.001_bib61) 2020; 395 Kishan (10.1016/j.prnil.2024.11.001_bib32) 2022; 23 Chow (10.1016/j.prnil.2024.11.001_bib63) 2023; 84 Nowakowska (10.1016/j.prnil.2024.11.001_bib28) 2021; 4 Aikawa (10.1016/j.prnil.2024.11.001_bib20) 2023; 11 Xie (10.1016/j.prnil.2024.11.001_bib49) 2017; 35 Choi (10.1016/j.prnil.2024.11.001_bib29) 2022; 14 Gharzai (10.1016/j.prnil.2024.11.001_bib51) 2021; 22 Falagario (10.1016/j.prnil.2024.11.001_bib4) 2023; 6 Jackson (10.1016/j.prnil.2024.11.001_bib18) 2013; 31 Pollack (10.1016/j.prnil.2024.11.001_bib44) 2022; 399 Ma (10.1016/j.prnil.2024.11.001_bib38) 2023; 41 Zhao (10.1016/j.prnil.2024.11.001_bib60) 2017; 3 Pound (10.1016/j.prnil.2024.11.001_bib5) 1999; 281 Polkinghorn (10.1016/j.prnil.2024.11.001_bib34) 2013; 3 Chung (10.1016/j.prnil.2024.11.001_bib21) 2024; 12 Goodwin (10.1016/j.prnil.2024.11.001_bib35) 2013; 3 Stephenson (10.1016/j.prnil.2024.11.001_bib19) 2007; 25 Soifer (10.1016/j.prnil.2024.11.001_bib24) 2012; 287 Nguyen (10.1016/j.prnil.2024.11.001_bib47) 2023; 41 Jackson (10.1016/j.prnil.2024.11.001_bib17) 2018; 1 Nowakowska (10.1016/j.prnil.2024.11.001_bib27) 2023; 9 Ahmed (10.1016/j.prnil.2024.11.001_bib14) 2017; 197 Ueda (10.1016/j.prnil.2024.11.001_bib48) 2024; 14 Shipley (10.1016/j.prnil.2024.11.001_bib40) 2017; 376 Xie (10.1016/j.prnil.2024.11.001_bib50) 2024; 35 |
References_xml | – volume: 1 start-page: 276 year: 2018 ident: 10.1016/j.prnil.2024.11.001_bib17 article-title: Impact of Biochemical Failure After Salvage Radiation Therapy on Prostate Cancer-specific Mortality: Competition Between Age and Time to Biochemical Failure publication-title: Eur. Urol. Oncol. doi: 10.1016/j.euo.2018.04.014 contributor: fullname: Jackson – volume: 35 start-page: 285 year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib50 article-title: Validation of metastasis-free survival as a surrogate endpoint for overall survival in localized prostate cancer in the era of docetaxel for castration-resistant prostate cancer publication-title: Ann. Oncol doi: 10.1016/j.annonc.2023.11.017 contributor: fullname: Xie – year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib39 article-title: Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer publication-title: Prostate Cancer Prostatic Dis doi: 10.1038/s41391-024-00811-5 contributor: fullname: Fecteau – volume: 38 start-page: 2830 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib65 article-title: Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial publication-title: J. Clin. Oncol. doi: 10.1200/JCO.20.00818 contributor: fullname: Palma – volume: 16 start-page: 491 year: 2012 ident: 10.1016/j.prnil.2024.11.001_bib25 article-title: The side effects of hormonal therapy at the patients with prostate cancer publication-title: Contemp. Oncol. (Poznan, Poland) contributor: fullname: Ziółkowska – volume: 35 start-page: 3097 year: 2017 ident: 10.1016/j.prnil.2024.11.001_bib49 article-title: Metastasis-Free Survival Is a Strong Surrogate of Overall Survival in Localized Prostate Cancer publication-title: J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. doi: 10.1200/JCO.2017.73.9987 contributor: fullname: Xie – volume: 75 start-page: 4688 year: 2015 ident: 10.1016/j.prnil.2024.11.001_bib37 article-title: Androgen Receptor Upregulation Mediates Radioresistance after Ionizing Radiation publication-title: Cancer Res. doi: 10.1158/0008-5472.CAN-15-0892 contributor: fullname: Spratt – volume: 66 start-page: 204 year: 2014 ident: 10.1016/j.prnil.2024.11.001_bib2 article-title: Optimal Definition of Biochemical Recurrence After Radical Prostatectomy Depends on Pathologic Risk Factors: Identifying Candidates for Early Salvage Therapy publication-title: Eur. Urol. doi: 10.1016/j.eururo.2013.08.022 contributor: fullname: Mir – volume: 9 start-page: 930 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib27 article-title: Association of Second-generation Antiandrogens With Cognitive and Functional Toxic Effects in Randomized Clinical Trials: A Systematic Review and Meta-analysis publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2023.0998 contributor: fullname: Nowakowska – volume: 96 start-page: 1046 year: 2016 ident: 10.1016/j.prnil.2024.11.001_bib9 article-title: Salvage Radiation Therapy Dose Response for Biochemical Failure of Prostate Cancer After Prostatectomy—A Multi-Institutional Observational Study publication-title: Int. J. Radiat. Oncol. doi: 10.1016/j.ijrobp.2016.08.043 contributor: fullname: Pisansky – volume: 23 start-page: 304 year: 2022 ident: 10.1016/j.prnil.2024.11.001_bib32 article-title: Androgen deprivation therapy use and duration with definitive radiotherapy for localised prostate cancer: an individual patient data meta-analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(21)00705-1 contributor: fullname: Kishan – volume: 11 start-page: 145 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib20 article-title: Predictive factors for disease progression after salvage radiation therapy in biochemical recurrent patients treated by radical prostatectomy publication-title: Prostate Int doi: 10.1016/j.prnil.2023.04.001 contributor: fullname: Aikawa – volume: 93 start-page: 233 year: 2004 ident: 10.1016/j.prnil.2024.11.001_bib54 article-title: Prostate specific antigen gene regulation by androgen receptor publication-title: J. Cell. Biochem. doi: 10.1002/jcb.20228 contributor: fullname: Kim – volume: 12 start-page: 90 year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib21 article-title: Association between preradiation therapy prostate-specific antigen levels and radiation therapy failure after prostatectomy: a propensity score matched analysis publication-title: Prostate Int doi: 10.1016/j.prnil.2024.03.001 contributor: fullname: Chung – volume: 1 start-page: 293 year: 1941 ident: 10.1016/j.prnil.2024.11.001_bib22 article-title: Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate publication-title: Cancer Res. contributor: fullname: Huggins – volume: 21 start-page: 1331 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib12 article-title: Adjuvant radiotherapy versus early salvage radiotherapy following radical prostatectomy (TROG 08.03/ANZUP RAVES): a randomised, controlled, phase 3, non-inferiority trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30456-3 contributor: fullname: Kneebone – volume: 17 start-page: 747 year: 2016 ident: 10.1016/j.prnil.2024.11.001_bib42 article-title: Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(16)00111-X contributor: fullname: Carrie – volume: 177 start-page: 540 year: 2007 ident: 10.1016/j.prnil.2024.11.001_bib1 article-title: Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the r publication-title: J. Urol. doi: 10.1016/j.juro.2006.10.097 contributor: fullname: Cookson – volume: 126 start-page: 244 year: 2018 ident: 10.1016/j.prnil.2024.11.001_bib16 article-title: Delineating sites of failure following post-prostatectomy radiation treatment using 68Ga-PSMA-PET publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2017.10.022 contributor: fullname: Byrne – volume: 84 start-page: 36 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib63 article-title: Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analy publication-title: Eur. Urol. doi: 10.1016/j.eururo.2023.03.001 contributor: fullname: Chow – volume: 22 start-page: 6 year: 2019 ident: 10.1016/j.prnil.2024.11.001_bib62 article-title: More advantages in detecting bone and soft tissue metastases from prostate cancer using (18)F-PSMA PET/CT publication-title: Hellenic journal of nuclear medicine contributor: fullname: Pianou – volume: 393 start-page: 2051 year: 2019 ident: 10.1016/j.prnil.2024.11.001_bib66 article-title: Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial publication-title: Lancet doi: 10.1016/S0140-6736(18)32487-5 contributor: fullname: Palma – volume: 5 start-page: 856 year: 2019 ident: 10.1016/j.prnil.2024.11.001_bib64 article-title: Assessment of 68Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2019.0096 contributor: fullname: Fendler – volume: 98 start-page: 715 year: 2006 ident: 10.1016/j.prnil.2024.11.001_bib3 article-title: Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy publication-title: J. Natl. Cancer Inst. doi: 10.1093/jnci/djj190 contributor: fullname: Stephenson – volume: 6 start-page: 735 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib41 article-title: Association of Presalvage Radiotherapy PSA Levels After Prostatectomy With Outcomes of Long-term Antiandrogen Therapy in Men With Prostate Cancer publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2020.0109 contributor: fullname: Dess – volume: 376 start-page: 417 year: 2017 ident: 10.1016/j.prnil.2024.11.001_bib40 article-title: Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa1607529 contributor: fullname: Shipley – volume: 396 start-page: 1422 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib13 article-title: Adjuvant or early salvage radiotherapy for the treatment of localised and locally advanced prostate cancer: a prospectively planned systematic review and meta-analysis of aggregate data publication-title: Lancet doi: 10.1016/S0140-6736(20)31952-8 contributor: fullname: Vale – volume: 287 start-page: 3777 year: 2012 ident: 10.1016/j.prnil.2024.11.001_bib24 article-title: Direct Regulation of Androgen Receptor Activity by Potent CYP17 Inhibitors in Prostate Cancer Cells publication-title: J. Biol. Chem. doi: 10.1074/jbc.M111.261933 contributor: fullname: Soifer – volume: 20 start-page: 1740 year: 2019 ident: 10.1016/j.prnil.2024.11.001_bib43 article-title: Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial publication-title: Lancet Oncol doi: 10.1016/S1470-2045(19)30486-3 contributor: fullname: Carrie – volume: 3 start-page: 1254 year: 2013 ident: 10.1016/j.prnil.2024.11.001_bib35 article-title: A Hormone–DNA Repair Circuit Governs the Response to Genotoxic Insult publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-13-0108 contributor: fullname: Goodwin – volume: 78 start-page: 64 year: 2018 ident: 10.1016/j.prnil.2024.11.001_bib36 article-title: Enhanced radiosensitization of enzalutamide via schedule dependent administration to androgen-sensitive prostate cancer cells publication-title: Prostate doi: 10.1002/pros.23445 contributor: fullname: Ghashghaei – volume: 31 start-page: 167 year: 2013 ident: 10.1016/j.prnil.2024.11.001_bib18 article-title: PSA doubling time of ≤6 months as the optimal cutoff for predicting clinically relevant outcomes for men receiving salvage radiation therapy post radical prostatectomy publication-title: J. Clin. Oncol. doi: 10.1200/jco.2013.31.6_suppl.167 contributor: fullname: Jackson – volume: 39 start-page: 2284 year: 2021 ident: 10.1016/j.prnil.2024.11.001_bib8 article-title: Adjuvant Versus Early Salvage Radiation Therapy for Men at High Risk for Recurrence Following Radical Prostatectomy for Prostate Cancer and the Risk of Death publication-title: J. Clin. Oncol. doi: 10.1200/JCO.20.03714 contributor: fullname: Tilki – volume: 3 start-page: 1245 year: 2013 ident: 10.1016/j.prnil.2024.11.001_bib34 article-title: Androgen Receptor Signaling Regulates DNA Repair in Prostate Cancers publication-title: Cancer Discov. doi: 10.1158/2159-8290.CD-13-0172 contributor: fullname: Polkinghorn – volume: 396 start-page: 1413 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib7 article-title: Timing of radiotherapy after radical prostatectomy (RADICALS-RT): a randomised, controlled phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(20)31553-1 contributor: fullname: Parker – volume: 6 start-page: 650 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib67 article-title: Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2020.0147 contributor: fullname: Phillips – volume: 34 start-page: 3648 year: 2016 ident: 10.1016/j.prnil.2024.11.001_bib15 article-title: Contemporary Update of a Multi-Institutional Predictive Nomogram for Salvage Radiotherapy After Radical Prostatectomy publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2016.67.9647 contributor: fullname: Tendulkar – volume: 116 start-page: 521 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib58 article-title: Analysis of a Biopsy-Based Genomic Classifier in High-Risk Prostate Cancer: Meta-Analysis of the NRG Oncology/Radiation Therapy Oncology Group 9202, 9413, and 9902 Phase 3 Randomized Trials publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2022.12.035 contributor: fullname: Nguyen – volume: 399 start-page: 1886 year: 2022 ident: 10.1016/j.prnil.2024.11.001_bib44 article-title: The addition of androgen deprivation therapy and pelvic lymph node treatment to prostate bed salvage radiotherapy (NRG Oncology/RTOG 0534 SPPORT): an international, multicentre, randomised phase 3 trial publication-title: Lancet doi: 10.1016/S0140-6736(21)01790-6 contributor: fullname: Pollack – year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib45 article-title: Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial publication-title: Lancet contributor: fullname: Parker – volume: 22 start-page: 402 year: 2021 ident: 10.1016/j.prnil.2024.11.001_bib51 article-title: Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis publication-title: Lancet Oncol doi: 10.1016/S1470-2045(20)30730-0 contributor: fullname: Gharzai – volume: 13 start-page: 632 year: 2022 ident: 10.1016/j.prnil.2024.11.001_bib23 article-title: Second generation androgen receptor antagonists and challenges in prostate cancer treatment publication-title: Cell Death Dis. doi: 10.1038/s41419-022-05084-1 contributor: fullname: Chen – volume: 14 start-page: 87 year: 2022 ident: 10.1016/j.prnil.2024.11.001_bib29 article-title: Evolution of Androgen Deprivation Therapy (ADT) and Its New Emerging Modalities in Prostate Cancer: An Update for Practicing Urologists, Clinicians and Medical Providers publication-title: Res. reports Urol. doi: 10.2147/RRU.S303215 contributor: fullname: Choi – volume: 14 start-page: 705 year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib48 article-title: Apalutamide versus bicalutamide in combination with androgen deprivation therapy for metastatic hormone sensitive prostate cancer publication-title: Sci. Rep. doi: 10.1038/s41598-024-51389-w contributor: fullname: Ueda – volume: 1 start-page: 385 year: 2003 ident: 10.1016/j.prnil.2024.11.001_bib53 article-title: Androgen Receptor Activity at the Prostate Specific Antigen Locus: Steroidal and Non-Steroidal Mechanisms1 publication-title: Mol. Cancer Res. contributor: fullname: Jia – volume: 80 start-page: 306 year: 2021 ident: 10.1016/j.prnil.2024.11.001_bib11 article-title: Dose-intensified Versus Conventional-dose Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: The SAKK 09/10 Randomized Phase 3 Trial publication-title: Eur. Urol. doi: 10.1016/j.eururo.2021.05.033 contributor: fullname: Ghadjar – volume: 8 start-page: 1 year: 2013 ident: 10.1016/j.prnil.2024.11.001_bib57 article-title: Discovery and Validation of a Prostate Cancer Genomic Classifier that Predicts Early Metastasis Following Radical Prostatectomy publication-title: PLoS One doi: 10.1371/journal.pone.0066855 contributor: fullname: Erho – year: 2014 ident: 10.1016/j.prnil.2024.11.001_bib56 article-title: Non‐steroidal antiandrogen monotherapy compared with luteinising hormone–releasing hormone agonists or surgical castration monotherapy for advanced prostate cancer publication-title: Cochrane Database Syst. Rev. contributor: fullname: Meerpohl – volume: 79 start-page: 374 year: 2021 ident: 10.1016/j.prnil.2024.11.001_bib59 article-title: A Systematic Review of the Evidence for the Decipher Genomic Classifier in Prostate Cancer publication-title: Eur. Urol. doi: 10.1016/j.eururo.2020.11.021 contributor: fullname: Jairath – year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib68 article-title: Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography on Prostate Cancer Salvage Radiotherapy Management: Results from a Prospective Multicenter Randomized Phase 3 Trial (PSMA-SRT NCT03582774) publication-title: Eur. Urol. contributor: fullname: Armstrong – volume: 183 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib31 article-title: ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancer publication-title: Radiother. Oncol. doi: 10.1016/j.radonc.2023.109544 contributor: fullname: Schmidt-Hegemann – volume: 3 start-page: 1663 year: 2017 ident: 10.1016/j.prnil.2024.11.001_bib60 article-title: Associations of Luminal and Basal Subtyping of Prostate Cancer With Prognosis and Response to Androgen Deprivation Therapy publication-title: JAMA Oncol doi: 10.1001/jamaoncol.2017.0751 contributor: fullname: Zhao – volume: 67 start-page: 825 year: 2015 ident: 10.1016/j.prnil.2024.11.001_bib26 article-title: Adverse effects of androgen deprivation therapy and strategies to mitigate them publication-title: Eur. Urol. doi: 10.1016/j.eururo.2014.07.010 contributor: fullname: Nguyen – volume: 73 start-page: 156 year: 2018 ident: 10.1016/j.prnil.2024.11.001_bib55 article-title: A Systematic Review and Framework for the Use of Hormone Therapy with Salvage Radiation Therapy for Recurrent Prostate Cancer publication-title: Eur. Urol. doi: 10.1016/j.eururo.2017.06.027 contributor: fullname: Spratt – volume: 25 start-page: 2035 year: 2007 ident: 10.1016/j.prnil.2024.11.001_bib19 article-title: Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy publication-title: J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. doi: 10.1200/JCO.2006.08.9607 contributor: fullname: Stephenson – volume: 41 start-page: 881 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib38 article-title: Sequencing of Androgen-Deprivation Therapy of Short Duration With Radiotherapy for Nonmetastatic Prostate Cancer (SANDSTORM): A Pooled Analysis of 12 Randomized Trials publication-title: J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. doi: 10.1200/JCO.22.00970 contributor: fullname: Ma – volume: 281 start-page: 1591 year: 1999 ident: 10.1016/j.prnil.2024.11.001_bib5 article-title: Natural History of Progression After PSA Elevation Following Radical Prostatectomy publication-title: JAMA doi: 10.1001/jama.281.17.1591 contributor: fullname: Pound – volume: 106 start-page: 282 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib10 article-title: Toxicity and Biochemical Outcomes of Dose-Intensified Postoperative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial publication-title: Int. J. Radiat. Oncol. Biol. Phys. doi: 10.1016/j.ijrobp.2019.09.047 contributor: fullname: Qi – volume: 197 start-page: 662 year: 2017 ident: 10.1016/j.prnil.2024.11.001_bib14 article-title: Very Early Salvage Radiotherapy Improves Distant Metastasis-Free Survival publication-title: J. Urol. doi: 10.1016/j.juro.2016.08.106 contributor: fullname: Ahmed – volume: 395 start-page: 1208 year: 2020 ident: 10.1016/j.prnil.2024.11.001_bib61 article-title: Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study publication-title: Lancet doi: 10.1016/S0140-6736(20)30314-7 contributor: fullname: Hofman – volume: 26 start-page: 30 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib33 article-title: Second generation anti-androgens and androgen deprivation therapy with radiation therapy in the definitive management of high-risk prostate cancer publication-title: Prostate Cancer Prostatic Dis. doi: 10.1038/s41391-022-00598-3 contributor: fullname: Wang – volume: 40 start-page: 3172 year: 2022 ident: 10.1016/j.prnil.2024.11.001_bib52 article-title: Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601 publication-title: J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. doi: 10.1200/JCO.21.02741 contributor: fullname: Jackson – volume: 4 start-page: e2140803 year: 2021 ident: 10.1016/j.prnil.2024.11.001_bib28 article-title: Association of Second-generation Antiandrogens With Depression Among Patients With Prostate Cancer publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2021.40803 contributor: fullname: Nowakowska – volume: 18 start-page: 433 year: 2021 ident: 10.1016/j.prnil.2024.11.001_bib30 article-title: Treatment and trials in non-metastatic castration-resistant prostate cancer publication-title: Nat. Rev. Urol. doi: 10.1038/s41585-021-00470-4 contributor: fullname: Lokeshwar – volume: 197 start-page: 129 year: 2017 ident: 10.1016/j.prnil.2024.11.001_bib6 article-title: Contemporary Mapping of Post-Prostatectomy Prostate Cancer Relapse with 11C-Choline Positron Emission Tomography and Multiparametric Magnetic Resonance Imaging publication-title: J. Urol. doi: 10.1016/j.juro.2016.07.073 contributor: fullname: Sobol – volume: 6 start-page: e2332900 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib4 article-title: Biochemical Recurrence and Risk of Mortality Following Radiotherapy or Radical Prostatectomy publication-title: JAMA Netw. Open doi: 10.1001/jamanetworkopen.2023.32900 contributor: fullname: Falagario – year: 2024 ident: 10.1016/j.prnil.2024.11.001_bib46 article-title: Duration of androgen deprivation therapy with postoperative radiotherapy for prostate cancer: a comparison of long-course versus short-course androgen deprivation therapy in the RADICALS-HD randomised trial publication-title: Lancet contributor: fullname: Parker – volume: 41 start-page: 303 year: 2023 ident: 10.1016/j.prnil.2024.11.001_bib47 article-title: FORMULA-509: A multicenter randomized trial of post-operative salvage radiotherapy (SRT) and 6 months of GnRH agonist with or without abiraterone acetate/prednisone (AAP) and apalutamide (Apa) post-radical prostatectomy (RP) publication-title: J. Clin. Oncol. doi: 10.1200/JCO.2023.41.6_suppl.303 contributor: fullname: Nguyen |
SSID | ssj0000941995 |
Score | 2.335199 |
SecondaryResourceType | review_article |
SourceID | crossref |
SourceType | Aggregation Database |
Title | Concurrent antiandrogen therapy in the salvage radiotherapy setting for recurrent prostate cancer: a literature review |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3JasMwEBUhhdJL6UrXoEOPVYgXKVKhlBIaQiE9JZCbkWQZEoKd2mlo_r4zXtoccunNxkaHkex5j5k3j5AHHXOufe1YIqRiYd9wprm1TAfCaamtTAQKnMcfYjQN32d81iKNK2odwGIvtUM_qWm-7H5_bl_gg3_-69Va5ekc6wh-2MWRnKjnOvAhNWKP17jG-4uqjQ4lyWg4B0yBAfvzm0lE-9fZyVY7aWd4Qo5rvEhfqw0-JS2XnpHDcV0RPyebQZbaasYShSDBZsd5BoeCVsKqLZ2Xl7TQyw38Omiu43nWPCtc2fVMAbjS3DXLrFAIAhCUWjwR-RPVdPk7fJlWWpcLMhm-TQYjVnspMKukx1xYFiiDfmI8TxiXKKGccxzIhdFovqHjwPac7AFhtcazglv05JC9RFrf-jy4JO00S90VoaEATmuNn0ihw75VgBATFSpnINfHwLWvyWMTsmhVTcyImlayRVRGOMIIA_fAhrqb_71-S47wrlID3pH2Ov9y9wAL1qZT0ulOueE_4Yi4pw |
link.rule.ids | 314,780,784,864,24318,27924,27925 |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Concurrent+antiandrogen+therapy+in+the+salvage+radiotherapy+setting+for+recurrent+prostate+cancer%3A+a+literature+review&rft.jtitle=Prostate+international&rft.au=Mannar%2C+Dhiraj&rft.au=Urban%2C+Ryan&rft.au=Zhang%2C+Tina&rft.au=Peacock%2C+Michael&rft.date=2024-11-01&rft.issn=2287-8882&rft_id=info:doi/10.1016%2Fj.prnil.2024.11.001&rft.externalDBID=n%2Fa&rft.externalDocID=10_1016_j_prnil_2024_11_001 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2287-8882&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2287-8882&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2287-8882&client=summon |